Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1090-1091

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, U.
Right arrow Articles by Mezzetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, U.
Right arrow Articles by Mezzetti, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Coronary Artery Disease
Related Collections
Right arrow Restenosis
Right arrow Growth factors/cytokines
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1090.)
© 2001 American Heart Association, Inc.


Letters to the Editor

Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty

Uichi Ikeda; Kazuyuki Shimada

Department of Cardiology, Jichi Medical School, Tochigi, Japan

To the Editor:

We read with great interest the article by Cipollone et al1 on the expression of monocyte chemoattractant protein-1 (MCP-1) after percutaneous transluminal coronary angioplasty (PTCA). In their study, plasma MCP-1 levels were significantly increased 1 day after PTCA, and patients with restenosis showed significantly higher MCP-1 levels after PTCA than those without restenosis. Several previous studies, including our own, have revealed that PTCA induces inflammatory responses.2 In addition, we reported that MCP-1 is expressed in human atherosclerotic lesions3 and that the interaction between monocytes and endothelial cells induces MCP-1 expression and enhances monocyte migration.4 5 Therefore, like Cipollone et al,1 we hypothesized that MCP-1 played important roles in restenosis after intervention.

To prove our hypothesis, we examined 40 patients with angina pectoris who underwent elective PTCA for isolated stenotic lesions of the left coronary artery.6 A 5F Amplatz catheter was placed in the coronary sinus, and blood samples were obtained through the catheter before, immediately after, and 4 and 24 hours after angioplasty. Blood samples were also obtained from the femoral artery 24 hours after angioplasty. Plasma levels of MCP-1 and macrophage-colony stimulating factor (M-CSF) were measured by specific enzyme immunoassays. M-CSF levels in the coronary sinus blood showed a significant increase 4 and 24 hours after PTCA (from [mean±SD] 671±51 to 942±63 and to 1220±79 pg/mL, respectively). In the femoral arterial blood, a slight increase in M-CSF levels was found 24 hours after PTCA; however, the difference was not significant (from 681±135 to 865±156 pg/mL, P=0.155). . . . [Full Text of this Article]

Francesco Cipollone; Andrea Mezzetti

Department of Medicine and Aging Sciences, Policlinico SS Annunziata, University of Chieti, "G. D’annunzio," Chieti, Italy




This article has been cited by other articles:


Home page
CirculationHome page
P. K. Shah
Inflammation, Neointimal Hyperplasia, and Restenosis: As the Leukocytes Roll, the Arteries Thicken
Circulation, May 6, 2003; 107(17): 2175 - 2177.
[Full Text] [PDF]